The government shutdown is a low priority for investors

Markets turned higher this week on news of the government shutdown on October 1. It isn't the market's first rodeo in this area, so most investors are taking the long view.

The facts are that every government shutdown in history has been followed by a government reopening 100% of the time. Present betting indicates that this one could last anywhere from 10 to 29 days, but October 15 seems the most popular bet.

It wasn't too difficult to predict this government shutdown. Both parties sought the drama, hoping to galvanize their partisan constituencies. Thus far, only the media, politicians, and federal employees have expressed much concern about the fallout. For Wall Street, the absence of specific key economic data, such as today's lack of the jobs report, is uncomfortable and inconvenient but not dire.

At a time when so much depends on timely information, such as the Consumer Price Index and non-farm payrolls reports, the market is in the dark to some extent. The Fed, for example, is expected to cut interest rates again at the October meeting, but that depends on the job data. No data means less confidence. Of course, the last few months of labor reports from the Bureau of Labor Statistics have been nothing to write home about, so missing a report or two may not be all that disastrous.

My conspiracy theory of last week has proven more accurate than I suspected. I wrote that a shutdown would likely occur, sending the dollar and bond yields lower still, which are tactical goals of the U.S. Treasury Secretary, Scott Bessent. Better still, the president wants to cut spending in what he sees as liberal programs of the Democrats. So far, he has axed $8 billion in funding for green energy projects in 16 blue states, as well as $18 billion in infrastructure projects in New York. In addition, the shutdown provides him with an opportunity to reinvigorate his court-stalled DOGE agenda by firing more government employees.

 All of this can be accomplished in a shutdown while blaming the Democrats every step of the way. I am surprised that the Democrats fell for it, but politics is not my bailiwick. Given their experience thus far under a second Trump administration, they must question whether discussions with Republicans without this shutdown would ever yield a compromise solution.

 I do understand their desire to safeguard the health and well-being of millions who depend on Medicaid and Obamacare. And I do believe that Trump and his Republican legislators are worried about the optics of these issues as well, going into elections despite their tough stance today. Much of these spending cuts and firings, if they occur, will be overturned in the courts anyway, but it is the narrative, not the substance, that counts among voters today.

 As for investors, they are much more interested in the government's continued commitment to opening the floodgates of state capitalism. This week, it was all about Big Pharma. In exchange for reduced drug pricing, along with company commitments to invest in the U.S., Trump offered tariff relief on pharmaceutical imports.

 Pfizer was first to tip the scales by cutting drug prices on a host of older drugs in its pipeline. The president is also expecting more investment announcements from companies in that sector that will further his goal of relocating drug manufacturing back to the U.S.

However, that is just the tip of the iceberg. The administration is working on deals across as many as 30 industries, talking to dozens of companies that the government deems critical to national or economic security. The flurry of activity encompasses various segments of the economy, from semiconductors and quantum computing to non-tech areas such as energy, shipbuilding, battery production, critical minerals, and now pharmaceuticals. The administration maintains a list of 54 crucial minerals it is targeting, which is updated almost weekly. Six more minerals were added this week, along with Potash, the most recent addition.

Interest in equity stakes in companies now includes foreign companies as well. For example, the U.S. government has offered to purchase equity in Australian critical mineral companies as part of a funding package aimed at expanding its supply and reducing its reliance on China.

At the same time, the proliferation of new tariffs on industry and/or specific products has replaced the more sweeping country-wide levies that are now being adjudicated in the courts. As I advised readers in past columns, the courts may slow the tariff war but not end it. A 'Plan B' is already in progress. In preparation for a possible defeat of his use of the Emergency Powers Act, these new tariff efforts will follow a more traditional route.

Section 232 of the Trade Expansion Act of 1962 authorizes Trump to impose tariffs or quotas on imports if the product or industry is deemed to threaten national security. They are not subject to challenge. It is the reasoning behind his announcements of fresh investigations into lumber, movies, semiconductors, drugs, trucks, jet engines, and commercial aircraft, among others. The list can go on forever.

If these investigations determine that the products are a threat (and they will, since the investigators are all Trump supporters), tariffs are sure to follow. While these tariffs would be far less sweeping than his reciprocal tariffs, they offer significantly stronger legal protection. The race is on to accomplish all of this before the mid-term elections.

Stocks, bonds, commodities, and other assets continue to gain. The global bull market remains alive and well, with new highs almost daily. October, as we all know, is a dangerous month for the markets from a historical and seasonal perspective.

The risks are that this shutdown could provide the volatility that traders need to justify a sell-off if it lasts too long or takes an unexpected turn for the worse. Another concern is that the Fed might hold off on reducing rates again at the end of the month until it sees more data. I give that a lower probability.

However, on the other side of the ledger, there is a high probability that the Fed will cut interest rates again this month. Quarterly earnings announcements are also forecasted to be robust. My conclusion: stay invested, hedge a little if you feel worried, but otherwise ride the inflows higher.

Bill Schmick is a founding partner of Onota Partners, Inc., in the Berkshires.  Bill’s forecasts and opinions are purely his own and do not necessarily represent the views of Onota Partners, Inc. (OPI).  None of his commentary is or should be considered investment advice.  Direct your inquiries to Bill at 1-413-347-2401, email him at billiams1948@gmail.com, or visit his website at www.schmicksretiredinvestor.com. Investments in securities are not insured, protected or guaranteed and may result in loss of income and/or principal.